Evidence map›Paper›PMID 34403077›Full record

ArticleObesity surgery2021

Effect of Roux-en-Y Gastric Bypass with Different Lengths of Biliopancreatic and Alimentary Limbs for Patients with Type 2 Diabetes Mellitus and a BMI < 35 kg/m

Xiang Gao, Liyong Zhu, Guohui Wang, Weizheng Li, Zhi Song, Shaihong Zhu, Pengzhou Li

Abstract read
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiang GaoDepartment of General Surgery, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
Liyong ZhuDepartment of General Surgery, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
Guohui WangDepartment of General Surgery, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
Weizheng LiDepartment of General Surgery, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
Zhi SongDepartment of General Surgery, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
Shaihong ZhuDepartment of General Surgery, Third Xiangya Hospital, Central South University, Changsha, 410013, China.
Pengzhou LiDepartment of General Surgery, Third Xiangya Hospital, Central South University, Changsha, 410013, China. 602223@csu.edu.cn.ORCID http://orcid.org/0000-0003-0271-1765

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThere have been no definite conclusions about the biliopancreatic limb (BPL) and alimentary limb (AL) lengths in Roux-en-Y gastric bypass (RYGB) operations for different populations and BMIs. Western scholars have performed many studies on the lengths of the BPL and AL in patients with a BMI ≥ 35 kg/m PATIENTS AND

methodsClinical data were collected prospectively and analyzed retrospectively for 87 patients with type 2 diabetes (T2DM) who underwent RYGB with a BPL of 50 cm and an AL of 50 cm (BPL50/AL50) or with a BPL of 100 cm and an AL of 100 cm (BPL100/AL100) and who were followed up for 5 years.

resultsThe cohort included 42 patients in the BPL50/AL50 group and 45 patients in the BPL100/AL100 group. At 5 years, there were significant differences in BMI, total weight loss (TWL%), glycosylated hemoglobin, and homeostasis model assessment insulin resistance between BPL50/AL50 and BPL100/AL100 (P < 0.05). Diabetes remission rate of the BPL100/AL100 group was significantly higher than that of the BPL50/AL50 group. Diabetes remission at 1 year after surgery correlated with the length limb (BPL + AL), duration of diabetes and TWL%. There was no difference in complications between BPL50/AL50 and BPL100/AL100.

conclusionsRYGB with BPL100/AL100 is a safe and effective treatment for diabetic patients with a BMI < 35 kg/m

Indexed as

Diabetes Mellitus, Type 2Gastric BypassObesity, MorbidBody Mass IndexChinaHumansRetrospective StudiesTreatment OutcomeBody Mass IndexObesityRoux-en-Y gastric bypassType 2 diabetes

Identifiers

PMID34403077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.